Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
|
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [21] Glucuronidation of flavonoids by human UGT1A3, UGT1A9 and structure-activity relationships
    Xie, Shenggu
    Chen, Yakun
    Chen, Shuqing
    Zeng, Su
    DRUG METABOLISM REVIEWS, 2006, 38 : 129 - 129
  • [22] Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7
    Wu, Zhufeng
    Liu, Hongming
    Wu, Baojian
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (04) : 583 - 596
  • [23] Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen
    Wang, Haina
    Yuan, Lingmin
    Zeng, Su
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) : 1757 - 1763
  • [24] Differences in the regulation of the UGT1A1, UGT1A6, UGT2B4 and UGT2B7 genes in human liver and small intestine define tissue specific and interindividual glucuronidation activities.
    Strassburg, CP
    Kneip, S
    Topp, J
    Obermayer-Straub, P
    Turkey, RH
    Manns, MP
    HEPATOLOGY, 2000, 32 (04) : 330A - 330A
  • [25] N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7
    Staines, AG
    Coughtrie, MWH
    Burchell, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03): : 1131 - 1137
  • [26] Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
    Matsumoto, Jun
    Nishimoto, Anzu
    Watari, Shogo
    Ueki, Hideo
    Shiromizu, Shoya
    Iwata, Naohiro
    Takeda, Tatsuaki
    Ushio, Soichiro
    Kajizono, Makoto
    Fujiyoshi, Masachika
    Koyama, Toshihiro
    Araki, Motoo
    Wada, Koichiro
    Zamami, Yoshito
    Nasu, Yasutomo
    Ariyoshi, Noritaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (08) : 1779 - 1790
  • [27] Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
    Jun Matsumoto
    Anzu Nishimoto
    Shogo Watari
    Hideo Ueki
    Shoya Shiromizu
    Naohiro Iwata
    Tatsuaki Takeda
    Soichiro Ushio
    Makoto Kajizono
    Masachika Fujiyoshi
    Toshihiro Koyama
    Motoo Araki
    Koichiro Wada
    Yoshito Zamami
    Yasutomo Nasu
    Noritaka Ariyoshi
    Molecular and Cellular Biochemistry, 2023, 478 : 1779 - 1790
  • [28] Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate
    Ji, Jin-Zi
    Huang, Bei-Bei
    Gu, Tong-Tong
    Tai, Ting
    Zhou, Huan
    Jia, Yu-Meng
    Mi, Qiong-Yu
    Zhang, Meng-Ran
    Xie, Hong-Guang
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (02) : 88 - 98
  • [29] Glucuronidation of 1-hydroxypyrene by human liver microsomes and human UDP-glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a high-sensitivity glucuronidation assay for human tissue
    Luukkanen, L
    Mikkola, J
    Forsman, T
    Taavitsainen, P
    Taskinen, J
    Elovaara, E
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (08) : 1096 - 1101
  • [30] Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7
    Gaiser, BK
    Lockley, DJ
    Staines, AG
    Baarnhielm, C
    Burchell, B
    XENOBIOTICA, 2003, 33 (11) : 1073 - 1083